{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:36Z","timestamp":1793146596179,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008359","name":"Digestive Diseases Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ijrobp.2024.10.010","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T13:52:02Z","timestamp":1729086722000},"page":"963-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes"],"prefix":"10.1016","volume":"121","author":[{"given":"Tom van den","family":"Ende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-7863","authenticated-orcid":false,"given":"Steven C.","family":"Kuijper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Widaatalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyanne A.","family":"Noortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris H.P.","family":"van Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ymke","family":"van der Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Michiel","family":"Pegtel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Mouliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioe-Fee","family":"de Geus-Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.10.010_bib0001","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0002","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0003","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0004","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0005","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA1","article-title":"Prospective randomized multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (ESOPEC trial)","volume":"42","author":"Hoeppner","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0007","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S2468-1253(23)00243-1","article-title":"Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): An open-label, randomised, phase 3 trial","volume":"8","author":"Reynolds","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0008","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrclinonc.2017.141","article-title":"Radiomics: The bridge between medical imaging and personalized medicine","volume":"14","author":"Lambin","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0009","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: Extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0010","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0011","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00259-021-05480-3","article-title":"18F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma","volume":"49","author":"Eertink","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0012","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/diagnostics12051070","article-title":"Prediction of non-response to neoadjuvant chemoradiotherapy in esophageal cancer patients with 18F-FDG PET radiomics based machine learning classification","volume":"12","author":"Beukinga","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0013","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1007\/s00330-020-07439-8","article-title":"Addition of HER2 and CD44 to 18F-FDG PET-based clinico-radiomic models enhances prediction of neoadjuvant chemoradiotherapy response in esophageal cancer","volume":"31","author":"Beukinga","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0014","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/cancers13133271","article-title":"A prospectively validated prognostic model for patients with locally advanced squamous cell carcinoma of the head and neck based on radiomics of computed tomography images","volume":"13","author":"Keek","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0015","series-title":"HNT-AI: An Automatic Segmentation Framework for Head and Neck Primary Tumors and Lymph Nodes in FDG-PET\/CT Images","first-page":"212","author":"Salahuddin","year":"2023"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.920393","article-title":"Predicting adverse radiation effects in brain tumors after stereotactic radiotherapy with deep learning and handcrafted radiomics","volume":"12","author":"Keek","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0017","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154941","article-title":"Circulating tumor DNA: Current challenges for clinical utility","volume":"132","author":"Dang","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0018","doi-asserted-by":"crossref","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0019","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.annonc.2020.12.010","article-title":"Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling","volume":"32","author":"Ococks","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0020","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2021.07.011","article-title":"Serial circulating tumor DNA detection using a personalized, tumor-informed assay in esophageal adenocarcinoma patients following resection","volume":"161","author":"Ococks","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0021","article-title":"Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis","volume":"5","author":"Moldovan","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245488","article-title":"Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients","volume":"16","author":"Wallander","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0023","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2020.7631","article-title":"SOURCE: Prediction models for overall survival in patients with metastatic and potentially curable esophageal and gastric cancer","volume":"19","author":"van den Boorn","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0024","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/cancers12040834","article-title":"External validation of the Dutch SOURCE survival prediction model in Belgian metastatic oesophageal and gastric cancer patients","volume":"12","author":"van Kleef","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0025","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1158\/1078-0432.CCR-20-4443","article-title":"Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: A single-arm Phase II feasibility trial (PERFECT)","volume":"27","author":"van den Ende","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0026","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","article-title":"FDG PET\/CT: EANM procedure guidelines for tumour imaging: Version 2.0","volume":"42","author":"Boellaard","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0027","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0028","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0029","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1148\/radiol.14132807","article-title":"Repeatability of metabolically active tumor volume measurements with FDG PET\/CT in advanced gastrointestinal malignancies: A multicenter study","volume":"273","author":"Frings","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0031","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cpet.2021.06.007","article-title":"Radiomics in PET imaging: A practical guide for newcomers","volume":"16","author":"Orlhac","year":"2021","journal-title":"PET Clin"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0032","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","article-title":"The sva package for removing batch effects and other unwanted variation in high-throughput experiments","volume":"28","author":"Leek","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0033","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0034","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1007\/s00330-020-07174-0","article-title":"Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis","volume":"31","author":"Ligero","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0035","article-title":"Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis","volume":"5","author":"Moldovan","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0036","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.6175","article-title":"Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma","volume":"261","author":"van den Ende","year":"2023","journal-title":"J Pathol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0037","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/hvac029","article-title":"The effect of preanalytical and physiological variables on cell-free DNA fragmentation","volume":"68","author":"van der Pol","year":"2022","journal-title":"Clin Chem"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0038","unstructured":"Peeters CFW \u00dcC, Mes SW. Stable prediction with radiomics data. ArXiv. 2019:2019;abs\/1903.11696."},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0040","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","article-title":"MissForest\u2014non-parametric missing value imputation for mixed-type data","volume":"28","author":"Stekhoven","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2020.103496","article-title":"A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models","volume":"108","author":"Longato","year":"2020","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0042","doi-asserted-by":"crossref","first-page":"e853","DOI":"10.1016\/S2589-7500(22)00188-1","article-title":"Interpreting area under the receiver operating characteristic curve","volume":"4","author":"de Hond","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0043","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2967\/jnumed.119.235325","article-title":"The dark side of radiomics: On the paramount importance of publishing negative results","volume":"60","author":"Buvat","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0044","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2288-13-33","article-title":"External validation of a Cox prognostic model: Principles and methods","volume":"13","author":"Royston","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0045","doi-asserted-by":"crossref","first-page":"g7594","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0046","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/hed.27299","article-title":"The role of radiomics in tongue cancer: A new tool for prognosis prediction","volume":"45","author":"Mossinelli","year":"2023","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0047","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1007\/s00330-018-5861-9","article-title":"Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection","volume":"29","author":"Li","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0048","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/s41467-022-30841-3","article-title":"Automated detection and segmentation of non-small cell lung cancer computed tomography images","volume":"13","author":"Primakov","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0049","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190948","article-title":"Radiomics: From qualitative to quantitative imaging","volume":"93","author":"Rogers","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0050","article-title":"Diagnosis of idiopathic pulmonary fibrosis in high-resolution computed tomography scans using a combination of handcrafted radiomics and deep learning","volume":"9","author":"Refaee","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0051","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/jpm11090842","article-title":"Making radiomics more reproducible across scanner and imaging protocol variations: A review of harmonization methods","volume":"11","author":"Mali","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0052","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1038\/s41598-022-12699-z","article-title":"Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma","volume":"12","author":"Fathi Kazerooni","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0053","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1038\/s41598-021-88239-y","article-title":"Combining radiomic phenotypes of non-small cell lung cancer with liquid biopsy data may improve prediction of response to EGFR inhibitors","volume":"11","author":"Yousefi","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0054","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","article-title":"Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: A multicentre observational study","volume":"4","author":"Feng","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100452","article-title":"ctDNA as a biomarker of progression in oesophageal adenocarcinoma","volume":"7","author":"Bonazzi","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0056","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.3390\/cancers14184417","article-title":"Circulating tumor DNA-based disease monitoring of patients with locally advanced esophageal cancer","volume":"14","author":"Hofste","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0057","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.molmed.2020.12.011","article-title":"Liquid biopsy of methylation biomarkers in cell-free DNA","volume":"27","author":"Luo","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110224","article-title":"A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancer","volume":"195","author":"McClurg","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0059","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s40259-022-00527-9","article-title":"Immunotherapy in gastro-oesophageal cancer: Current practice and the future of personalised therapy","volume":"36","author":"Booth","year":"2022","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0060","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.5832","article-title":"Tumor-immune landscape patterns before and after chemoradiation in resectable esophageal adenocarcinomas","volume":"256","author":"Soeratram","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102024","article-title":"MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma","volume":"86","author":"van Velzen","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0062","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nature20805","article-title":"Integrated genomic characterization of oesophageal carcinoma","volume":"541","author":"Asan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0063","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1954807","article-title":"Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma","volume":"10","author":"Goedegebuure","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0064","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.3390\/cancers14143515","article-title":"Delta-radiomics based on dynamic contrast-enhanced MRI predicts pathologic complete response in breast cancer patients treated with neoadjuvant chemotherapy","volume":"14","author":"Guo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0065","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11547-021-01436-7","article-title":"Delta radiomics: A systematic review","volume":"126","author":"Nardone","year":"2021","journal-title":"Radiol Med"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.990608","article-title":"Delta radiomics model for the prediction of progression-free survival time in advanced non-small-cell lung cancer patients after immunotherapy","volume":"12","author":"Xie","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0067","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.radonc.2021.08.023","article-title":"MRI-based delta-radiomics predicts pathologic complete response in high-grade soft-tissue sarcoma patients treated with neoadjuvant therapy","volume":"164","author":"Peeken","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0068","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3390\/cancers12051163","article-title":"18F-FDG pet parameters and radiomics features analysis in advanced Nsclc treated with immunotherapy as predictors of therapy response and survival","volume":"12","author":"Polverari","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0069","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2021202553","article-title":"The biological meaning of radiomic features","volume":"298","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0070","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1007\/s00330-020-07598-8","article-title":"Incorporating radiomics into clinical trials: Expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers","volume":"31","author":"Fournier","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijrobp.2024.10.010_bib0071","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrclinonc.2012.196","article-title":"Predicting outcomes in radiation oncology\u2013multifactorial decision support systems","volume":"10","author":"Lambin","year":"2013","journal-title":"Nat Rev Clin Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624034680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624034680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:46:52Z","timestamp":1740134812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624034680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0360301624034680"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating Clinical Variables, Radiomics, and Tumor-derived Cell-Free DNA for Enhanced Prediction of Resectable Esophageal Adenocarcinoma Outcomes","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}